FilingIndex
10-KThe Record

Kalaris Therapeutics, Inc. files 10-K

Filed Feb 15, 2023 · 3y ago · Accession 0000950170-23-002830

Plain English

Annual report — full-year financials, business overview, and risk factors.

Read the source below for the full document.

Read the original on SEC.gov ↗
Filing details
Ticker
KLRS
CIK
1754068
Form type
10-K
Filing date
Feb 15, 2023
Report date
Dec 31, 2022
Document
alvr-20221231.htm
Size
17.0 MB